News Crop protection
CTGB wants research into the relationship between GBM and Parkinson's
The Board for the Authorization of Plant Protection Products (CTGB) wants the European Food Safety Authority (EFSA) to investigate whether there is a relationship between the use of certain plant protection products (GBM) and Parkison's disease.
The Dutch CTBG requests in a letter the Executive Board of the European Food Safety Authority (EFSA) to carry out further analysis/research for the active substances that are currently authorized in Europe.
On behalf of LNV, RIVM is currently conducting an exploratory study into the data requirements for possible links between neurotoxicity and the development of neurodegenerative diseases. This is in response to social unrest that has arisen about this subject in recent years.
Difficult to establish relationship
In November 2020, Professor Bas Bloem, who specializes in this topic as a neurologist, gave a lecture about this to the board of the CTGB. He pointed out that establishing an unambiguous and causal relationship between active substances in PPPs and the development of Parkison is difficult. The first symptoms of the disease only appear after 10 to 15 years. There is growing experimental and epidemiological evidence supporting the relationship between certain pesticides and the risk of Parkinson's disease.
Parkinson's is the fastest growing neurological disease worldwide. This is fueling social unrest about toxic substances in the environment, such as PPPs. Various active substances on the market have never been specifically established at the time of approval whether they may be related to the development of Parkinson's disease.
Jurphaas Lugtenburg
© DCA Market Intelligence. This market information is subject to copyright. It is not permitted to reproduce, distribute, disseminate or make the content available to third parties for compensation, in any form, without the express written permission of DCA Market Intelligence.
